Health Economics & Market Access
Deliver your innovative solutions to patients through our strategic planning and effective implementations
Building up the value of your product and demonstrating it in an impactful way is critical to ensure optimal patient access. At Amaris Consulting, we help you bring your technology to life by guiding you through your strategic evidence planning options and ensuring high-quality and robust project execution. We combine our strategic vision and innovative methods to help you create and optimize your product proposition while navigating and managing data and market uncertainty.
Health Economics & Market Access
Center of Excellence at Amaris Consulting
We combine disease knowledge with strong strategic and analytical capabilities to help you deliver across all axes of health economics, outcomes research, value communications and market access.
Health economics & Disease modeling
Meta-analysis & Biostatistics
AI & Data sciences
Real-world data analytics
Evidence review & Value communication
Health Technology Assessments (HTAs)
Market access
Real-world data analytics
Here is the detail of the services we can offer:
We have developed more than 100 models on cost effectiveness and budget impacts for global organizations and country affiliates. We continuously innovate and apply new approaches to capture product value in the best possible way. Our models are transparent, user-friendly, and based on the latest and most scientifically rigorous methods.
- Epidemiological models
- Early modeling
- Cost-effectiveness & cost-utility modeling
- Budget impact modeling
- Model adaptations
- Modelling in R
Our statisticians are specifically trained to conduct robust meta-analyses and indirect treatment comparisons in support of health technology assessments (HTAs). Thanks to our multidisciplinary teams and our robust quantitative methodology, we can also help you analyze individual patient data (IPD) and provide strategic and technical guidance.
- Network meta-analyses (NMAs)
- Meta-regressions
- Fractional polynomial NMAs
- Matching adjusted indirect comparison (MAIC)
- Simulated treatment comparison (STC)
- Clinical trial data analyses
- Subgroup analyses
- Sensitivity analyses
- HTA required analyses
- Regulatory analyses
- Coding quality check
The promise of AI and big data in HEOR is becoming a reality, with new and exciting applications surfacing continuously. Our dedicated team of researchers can help you choose and apply the most appropriate AI methods to ensure robustness and transparency. We have concrete applications using both real-world evidence and secondary research that show how you can bring your data analytics to the next level.
- Machine learning algorithms
- Natural language processing
- AI applications to healthcare data analysis
- Development of predictive algorithms
- Text processing
We can help you design and implement retrospective and prospective real-world studies that focus on clinical, epidemiological, economic, and patient-reported outcomes. We can run studies using administrative claims data as well as individual patient data, covering the US, key European markets, and key markets in the Asia-Pacific region.
- Web surveys with patients or physicians
- Administrative database analyses
- Discrete choice experiments
- Retrospective chart reviews
- Mapping of real-world data sources
Analyzing evidence and communicating it in a clear and impactful way is a core competence of Amaris. Whether it is to support internal decision making or create your package for reimbursement submissions, we offer you the most complete, robust, and appropriate solution. Our team will help you manage data complexity and uncertainty while providing you with in-depth clinical expertise and interpretation.
- Systematic literature reviews (SLRs)
- Targeted literature reviews (TLRs)
- Evidence scanning services
- Global value & reimbursement dossiers
- Core value propositions
- Payer communication materials
- Evidence-generation plans
- Reimbursement of evidence support and advisory services
We have led and supported more than sixty submissions worldwide, covering established HTA markets as well as emerging ones. Our success is in the combination of strategic advice and robust analytical execution—all packaged in a clear and concise way. Our multidisciplinary teams of clinical experts, health economists, statisticians, and medical writers provide an end-to-end support for your product—before and during the evaluation process.
- Reimbursement dossier writing
- Reimbursement submission strategy
- Advisory boards organization
- Clinical and disease burden evidence adaptations
- Economic model adaptations
- HTA evidence packages
- Indirect treatment comparisons
- HTA-specific statistical analyses
Early planning is the right kind of planning, especially when it comes to payer strategy. Let us help you understand indication options, competition and payer needs, and guide you through the uncertainties you face—so you can better plan. Speak to our network of payers and experts to test your strategy and approach and proactively manage challenges and objections.
- Early market access strategy
- Early price potential
- Evidence package optimization
- Pricing and launch strategy
- Addressing payer concerns
- Internal workshops to align on strategy
- Managed entry agreements
Sector Solutions
The following is a non-exhaustive list of the sector solutions we provide. If you want to assess the relevance of these solutions to your own organization, please reach out to us.
Large pharmaceutical companies
Providing global, regional, and country-specific services covering oncology, rare diseases, infectious diseases, vaccines, immunology, and many other indications; working with advanced therapy medicinal products, such as cell and gene therapies, in addition to traditional molecules and therapeutics
Medical devices companies
Working with both small and large organizations and helping them through various HEOR, evidence generation, and value communication challenges; covering invasive devices, in-vitro diagnostics, digital applications, and many other types of technologies
Biotechs
Working with the senior HEOR and Access leadership of biotech companies to ensure innovation reaches patients in a way that also meets the company’s business objectives; providing a flexible and diverse set of services to match the expectations and needs of our less corporate customers
Non-governmental organizations
Supporting organizations such as the World Health Organization (WHO) with the robust analytical support necessary to ensure the management guidelines and recommendations they produce are of the expected quality
Why Choose Amaris Consulting?
At our Health Economics & Market Access Center of Excellence, we gather knowledge, experience, and resourceful teams to guide you through all your needs, from economics modeling to strategic market access, evidence generation, review and synthesis, real-world evidence, and value communication.
What makes us different?
We care about your project and product. Your journey is our journey! We are one team with one goal: to bring your innovative technology to patients.
We are independent. This is important for you because it means you have a flexible partner who can adapt to the evolving needs of your clinical program.
We innovate. In every project we do, through our practices and innovation teams, we work tirelessly to make HEOR methods and tools available to you.
Meet the Team
Petar ATANASOV
Aline GAUTHIER
